Introduction
Actinobacillus pleuropneumoniae is a member of the Pasteurellaceae family, and an important respiratory pathogen of swine. Economic losses in the swine industry worldwide are due to mortality associated with acute disease, and the medication cost for treatment and reduced production associated with chronic pleuropneumonia (Sassu et al., 2017) . Approaches to controlling the disease include good husbandry/biosecurity and vaccination to reduce incidence, and in the face of clinical disease, treatment with antibiotics to limit severity and spread (Sassu et al., 2017) .
It is useful to classify isolates of A. pleuropneumoniae not only for epidemiological purposes, but also to inform vaccine development (Gottschalk, 2012) . Broadly, isolates can be separated into two biovars, with the more prevalent biovar 1 type requiring exogenous nicotinamide adenine dinucleotide (NAD) for growth, and biovar 2 being NAD-independent (Pohl et al., 1983; Maldonado et al., 2009 ). Isolates can be further differentiated into serovars, based mainly on capsular A C C E P T E D M A N U S C R I P T antigens (Perry et al., 1990; Dubreuil et al., 2000) , and 16 serovars are currently recognized (Sárközi et al., 2015; Bossé et al., 2017a) .
With improved molecular diagnostics, including whole genome sequencing, it is possible to re-evaluate previously non-typable (NT) isolates, as well as isolates which present unusual serological or molecular diagnostic results. Recently, Morioka et al. (2016) showed that the methods of antigen preparation and serological testing, could influence the results for identification of certain serovars. Specifically, autoclaved antigens of forty-seven isolates proved un-typable in the agar gel diffusion assay, whereas rapid slide agglutination using formalin-fixed antigens identified all but two isolates as serovars 1, 2 or 15. The capsule types were confirmed by multiplex PCRs (mPCRs) (Bossé et al., 2014; Turni et al., 2014; Ito, 2010) , with the two remaining serologically NT isolates producing specific amplicons for serovars 2 and 15. Not all isolates of a given serovar were identified by all of the available mPCRs. The reason for the discrepancy between molecular and serological typing for these two isolates was not investigated; however it is possible that the presence of a transposon insertion in the CPS loci resulted in no serologically detectable capsule being produced. This was recently shown by Ito et al. (2016) who found that the presence of ISAplI insertions in the CPS loci of two isolates with serovar 15-specific capsule genes rendered them serologically NT.
The aim of this study was to investigate isolates of A. pleuropneumoniae previously designated serologically either as NT or as 'K2:07', but which did not amplify serovar-specific amplicons in mPCRs (Jessing et al., 2003; Schuchert et al., 2004; Angen et al., 2008) , by whole genome sequencing in order to determine the molecular organization of their CPS biosynthetic loci. Our results demonstrate the existence of two new serovars, 17 and 18, of A. pleuropneumoniae.
Materials and Methods

Clinical A. pleuropneumoniae isolates used in this study
Information regarding the proposed serovar 17 and 18 A. pleuropneumoniae isolates sequenced in this study is shown in Table 1 . The Danish biovar 1 isolates previously designated as serologically NT were shown to belong to a distinct phylogenetic cluster (c17) by amplified fragment length polymorphism (AFLP), and were all recovered from pigs on the same farm (Kokotovic and Angen, 2007) . Those designated as 'K2:O7' (also biovar 1) had been typed serologically by latex agglutination, but showed no serovar-specific bands when tested by mPCR (Angen et al., 2008; Bossé et al., 2014; Jessing et al., 2003; Schuchert et al., 2004) . The Canadian biovar 2 isolate, 14-022, recovered from the pneumonic lung of a pig in Ontario in 2014, was also found to be NT by serological and molecular methods (Bossé et al., 2014) . Information regarding nine additional isolates typed as serovar 17 or 18 by PCR is shown in Table 2 . Of these, two of the 'K2:O7' isolates (15360/96 and 12323/98) were previously reported to belong to the distinct AFLP phylogenetic cluster, c11 (Kokotovic and Angen, 2007) .
Genome sequencing and analysis
Genomic DNA was prepared from all isolates as previously described (Bossé et al., 2015) . The Microbes NG Sequencing Facility (www.microbesng.uk) generated and assembled the whole genome sequence of isolate 14-022; for all other samples, paired-end sequencing (Illumina HiSeq 2000) was performed at the Wellcome Trust
Sanger Institute (Cambridge, UK), analysed, and assembled and as previously described (Bossé et al., 2017b; Howell et al., 2013; Weinert et al., 2015) .
Genes of the CPS biosynthetic loci were identified in the draft genomes of each isolate by searching, using BLASTn (http://blast.ncbi.nlm.nih.gov /Blast.cgi), for the cpxD gene (accession AIA09380) from the capsule export locus, common to all serovars. The identified loci were analyzed using BLASTn and BLASTx. Multiple sequence alignments were performed using ClustalW in MacVector v15.5.2. Genes encoding Apx toxin biosynthetic and export proteins were also identified by BLASTn using sequences of apxICABD and apxIICA from the L20 genome (accession number CP000569), and apxIIICABD from the JL03 genome (accession number CP000687). The O-antigen biosynthesis loci were identified by tBLASTn using the erpA and rpsU genes (accession numbers WP_005617946 and WP_005598703, respectively) to delineate the flanking genes.
The sequences of the complete capsule loci for the serovar 17 and 18 isolates listed in Table 1 have been deposited in GenBank under accession numbers: MG780416 -MG780424.
Production of antisera
Hyperimmune rabbit polyclonal antisera were raised against formalin-killed preparations of isolates 16287-1 (Danish NT; proposed reference strain for serovar 17) and 7311555 (Danish 'K2:O7'; proposed reference strain for serovar 18), as previously described (Sárközi et al., 2015) .
Serological testing
Indirect hemagglutionation (IHA) was performed using antisera raised against the 16 recognised serovars (Sárközi et al., 2015) , as well as the new antisera raised in this study, as previously described (Sárközi et al., 2015) .
Diagnostic PCRs
Primers AP17F (TTGTAATGGCGGTGTAATGCTAC) and AP17R (CATAAGTGCAGCCATCTCTTTCAG) were designed to amplify a 302 bp serovar 17-specific amplicon; and primers AP18F (CGGAGTTTGGCAGCATAAAGG) and AP18R (CCATAATCGGTGCTCAACTAAGAATG) were designed to amplify a 514 bp fragment of the serovar 18-specific amplicon (see Fig. 1 for locations of primers).
These primers were combined, along with those previously designed (Bossé et al., 2014) for detection of the 418 bp apxIV band common to all serovars, and were initially tested using genomic DNA from the six Danish and one Canadian NT isolates (for serovar 17), and the two Danish 'K2:O7' isolates (for serovar 18), shown in Table 1 , as well as the reference strains for the 16 known serovars strains (i.e. 4074 T , 1536, S1421, M62, K17, L20, Femø, WF83, 405, CVJ13261, D13039, 56153, 8328, N-273, 3906, HS143, and A-85/14, respectively) . Subsequently, the specificity of the primers was further evaluated using the same 68 clinical isolates of A. pleuropneumoniae (covering serovars 1-15), the six A. pleuropneumoniae serovar 16 isolates, and the 31 porcine-associated species recently used for evaluation of serovar 16-specific primers (Bossé et al., 2017a) , as well as the nine clinical isolates shown in Table 2 .
Results and Discussion
The serovar 17 isolates (Table 1; proposed reference strain 16287-1) encode a type I CPS locus (Fig. 1A) , with the first three genes (cps17ABC) encoding a glycerol transferase, a glycerol-3-phosphate cytidylyltransferase, and a hypothetical protein, respectively, with high identity to those encoded by the first three genes in the loci of serovars 2, 3, 6, 7, 8, 9, 11 and 13 (Xu et al., 2010; Bossé et al., 2014) .
The serovar 17 CPS locus most closely resembles that of serovar 8, with 99% identity at the nucleotide level between the sequences cps17ABCDE and cps8ABCDE (Fig. 1A) . The cpsDE genes in both these serovars encode the same predicted glycosyltransferases. We previously reported (Bossé et al., 2014 ) that the CPS locus of the serovar 8 reference strain, 405, was comprised of these 5 genes.
However, upon further analysis of the sequences downstream of the cpsE gene in the draft genome sequence of strain 405, and in the complete genome sequence of MIDG2331 (Bossé et al., 2016) , a further three ORFs encoding hypothetical proteins (MIDG2331_01764, MIDG2331_01763, and MIDG2331_01762) are present that may also be part of the CPS biosynthetic locus, though the function of these proteins has yet to be determined.
In the serovar 17 CPS locus, the first 5 genes are followed by a single ORF The serovar 18 isolates (Table 1 ; proposed reference strain 7311555) encode a type II CPS locus (Fig. 1B) , with the first gene encoding a phosphotransferase sharing high identity with that encoded by the first gene in the loci of serovars 1, 4, 12, 14, and to a lesser extent with that of serovar 15 ( Xu et al., 2010; Ito, 2015; Ito and Sueyoshi, 2015) . CspC protein shares highest identity (55% over 361 AAs) with a predicted alpha/beta hydrolase from Cronobacter malonaticus (accession WP_032971501), whereas the serovar 1 CpsC shares highest identity (68% over 387 AAs) with a predicted Accessory Sec system GspB-transporter from Basfia succiniciproducens (accession numberSEP68412). The function of these CpsC proteins has yet to be determined.
In the serovar 1 CPS locus, there is an additional gene, cpsD, encoding a 347AA predicted acetyl transferase that is not present in the serovar 18 locus.
Results of Indirect Hemagglutination (IHA) using hyperimmune rabbit sera revealed homologous reactivity (titer of 2560) of the serovar 17 antiserum with the
proposed reference strain (16287-1), with similar titers (+/-one dilution) for other serovar 17 isolates, including 14-022, confirming both biovar 1 and biovar 2 isolates of serovar 17. Cross-reactivity (i.e. titers ≥ 640) was also detected between serovars 17 and 8 (titer of 1280 for the serovar 17 serum tested with the serovar 8 strain; but only a titer of 640 for the serovar 8 serum tested with the serovar 17 strain). In contrast, the serovar 18 antiserum was highly specific, giving a titer of 10240 with the proposed reference strain 7311555. These results are not surprising given the genetic data showing more unique genes for the serovar 18 locus, and the shared genes common to the CPS loci of serovars 8 and 17.
We identified the O-antigen genes in the sequenced serovar 17 and 18 isolates, located between the erpA and rpsU genes, as previously reported for other serovars of A. pleurpneumoniae (Xu et al., 2010) . BLASTn results for the serovar 17 O-antigen genes indicated 97-100% identity (over 13600 bp) with the loci in serovars 3, 6, 8, 15 (accession numbers CP000687, ADOG00000000, LN908249, and AB743837, respectively). Given that we only found serological cross-reactivity between serovar 17 and the serovar 8, it would appear that our IHA assay detected antibodies directed against CPS antigens, but not O-antigens. BLASTn analysis of the serovar 18 O-antigen genes revealed 97% identity (over 11340 bp) with the locus in serovar 7 (accession number CP001091). Again, our IHA results did not show cross-reactivity between serovars 18 and 7, indicating that antibodies directed against common O-antigens were not detected. However, it is likely that the previous serological designation of 'K2:O7' for these isolates was due to detection of Oantigen-specific antibodies.
For molecular diagnostics, we designed primers to amplify a unique 302 bp amplicon from the serovar 17 cpsF gene, and a unique 514 bp amplicon from the A C C E P T E D M A N U S C R I P T serovar 18 cpsB gene. When multiplexed, along with previously designed speciesspecific apxIV primers for detection of all A. pleuropneumoniae serovars (Bossé et al., 2014) , specific detection of the serovar 17 and 18 amplicons was seen with the respective proposed reference strains, with all of the other serovar reference strains only amplifying the apxIV amplicon (Fig. 2) . The specificity of the serovar 17 and 18 primers was further confirmed using the other sequenced serovar 17 and 18 isolates shown in Table 1 , as well as DNA from clinical isolates of A. pleuropneumoniae representing the 16 known serovars, other bacteria associated with pigs, and by virtual PCR using genome sequences available in Genbank, as previously described (Bossé et al., 2017a) .
PCR analysis of DNA samples from the isolates shown in Table 2 revealed that the recent biovar 2 NT isolates from the USA typed as serovar 17, as did two of the recent biovar 1 Spanish isolates (4443 and 4461). These two Spanish isolates were initially typed as serovar 8 by mPCR (Bossé et al., 2014) , whereas all of the North American biovar 2 isolates were NT in this assay. These results indicate that some serovar 17 isolates share the cpsAB sequences targeted by what were thought to be serovar 8-specific primers. Thus, in the past, some serovar 17 isolates may have been molecularly typed as serovar 8, depending on the primers used, or serologically as 3/6/8 if the test used detected O-antigens. Evidence supporting serovar 17 as separate from serovar 8 includes the segregation of the Danish NT isolates by AFLP into the c17 cluster distinct from serovar 8 isolates in c5 (Kokotovic and Angen, 2007) ; the lack of apxIIIABCD genes normally found in serovar 8 (see below); and the presence of only six CPS biosynthetic genes compared to eight genes found in the CPS locus of serovar 8. These 'K2:O7' isolates included 15360/96 and 12323/98, that had been shown to form a distinct AFLP cluster (c11), separate from other K2:O7 isolates found in cluster c8 (Kokotovic and Angen, 2007) . Whereas the K2:O7 isolates in c8 were found to produce amplicons for serovar 2, as well as serovar 8, when tested in mPCRs (Jessing et al., 2003; Schuchert et al., 2004) , those in c11 only produced a species-specific omlA amplicon (Jessing et al., 2003) . The primer pair used by Shuchert et al. (2004) for detection of serovar 8 was designed to amplify a 977 bp sequence from the cpsAB genes which are common to serovars with type I CPS loci, with different degrees of identity at the nucleotide level; whereas the serovar 2 primer pair amplified region spanning the cpsCD genes, the latter being less well conserved amongst type I CPS loci. Likewise, the serovar 2 primer pairs used by Jessing et al. (2003) were designed to amplify a 504 bp cpsD-specific region. Thus, the serovar 2 amplicon produced by the K2:O7 isolates in AFLP cluster c8 is likely specific for the serovar 2 CPS locus, whereas the serovar 8 amplicon is likely due to the presence of common priming sites in the cpsAB genes.
The distribution of genes encoding Apx toxins I-III differ depending on serovar, with some biovar 2 serovars showing different Apx toxin profiles than their biovar 1 counterparts (Sthitmatee et al., 2003; Rayamajhi et al., 2005; Maldonado et al., 2009) . Toxin typing PCRs have been used for characterizing isolates, since those producing ApxI tend to be more highly virulent (Frey et al., 1995; Sthitmatee et al., 2003; Rayamajhi et al., 2005; Maldonado et al., 2011) . The serovar 17 and 18
isolates sequenced in the current study, regardless of biovar, were all found to
harbor only the genes required for production of ApxII (apxIICA structural genes, and apxIBD export genes), a pattern similar to that reported for biovar 1 serovars 7 and 12, as well as biovar 2 isolates of serovars 2, 4, 7, 11 and 13 (Frey et al., 1995; Rayamajhi et al., 2005; Maldonado et al., 2009; Maldonado et al., 2011) . A number of Spanish biovar 2 NT isolates were also reported to produce only ApxII (Maldonado et al., 2009; Maldonado et al., 2011) . Testing of these isolates with our new mPCR would determine if any belong to serovars 17 or 18.
In conclusion, we have used a combination of whole genome sequencing and serology to clarify the status of previously NT isolates, as well as isolates previously mis-typed as 'K2:O7' (and unreactive in previous CPS-specific mPCRs), showing that they represent new serovars, 17 and 18 respectively, of A. pleuropneumoniae. 
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